Asset Impairment Charge, Number of Products Impaired, Not Expected To Achieve Forecasted Operating Results

No definition available.

Name:	prx_AssetImpairmentChargeNumberofProductsImpairedNotExpectedToAchieveForecastedOperatingResults
Namespace Prefix:	prx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228

+ Details

Name:	us-gaap_AssetImpairmentCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 35

-Paragraph 1

-Subparagraph b

-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 25

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Fair Value Measurements (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	12 Months Ended	3 Months Ended	9 Months Ended		3 Months Ended	12 Months Ended		9 Months Ended	12 Months Ended	9 Months Ended
	Sep. 30, 2013 product	Dec. 31, 2013 product	Dec. 31, 2013 IPR&D [Member]	Sep. 28, 2012 Predecessor [Member]	Dec. 31, 2013 Edict Acquisition [Member]	Jun. 30, 2013 Watson/Actavis Merger [Member]	Dec. 31, 2013 Watson/Actavis Merger [Member] Successor [Member]	Dec. 31, 2013 Anchen Acquisition [Member]	Sep. 28, 2012 Anchen Acquisition [Member] IPR&D [Member]	Dec. 31, 2013 Anchen Acquisition [Member] IPR&D [Member]	Sep. 28, 2012 Anchen Acquisition [Member] Predecessor [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent purchase price liabilities					$ 11,641
Asset impairment charges	$ 39,480		$ 60,147	$ 5,700		$ 466	$ 39,946	$ 100,093	$ 2,000	$ 60,147	$ 3,700
Number of products associated with IPR&D (projects)	5	6